Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. | Int J Mol Sci | 2021 | 33573316 | PubTator, text mining | PubMed |
| Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece. | Pharmaceutics | 2021 | 33572247 | PubTator, text mining | PubMed |
| Gene-environment interactions between air pollution and biotransformation enzymes and risk of birth defects. | Birth Defects Res | 2021 | 33569925 | PubTator, text mining | PubMed |
| Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency. | Mol Genet Genomic Med | 2021 | 33560599 | PubTator, text mining | PubMed |
| Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [11C]Metoclopramide in Mice. | Pharm Res | 2021 | 33559045 | PubTator, text mining | PubMed |
| Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm). | Hum Genome Var | 2021 | 33542200 | PubTator, text mining | PubMed |
| Phytochemistry, Bioactivities, Pharmacokinetics and Toxicity Prediction of Selaginella repanda with Its Anticancer Potential against Human Lung, Breast and Colorectal Carcinoma Cell Lines. | Molecules | 2021 | 33540783 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. | Clin Pharmacokinet | 2021 | 33527213 | PubTator, text mining | PubMed |
| 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer. | Sci Adv | 2021 | 33523930 | PubTator, text mining | PubMed |
| Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies. | Chem Phys Lett | 2021 | 33518774 | PubTator, text mining | PubMed |
| Platinum accumulation in oxaliplatin-induced peripheral neuropathy. | J Peripher Nerv Syst | 2021 | 33462873 | PubTator, text mining | PubMed |
| Genetics of 35 blood and urine biomarkers in the UK Biobank. | Nat Genet | 2021 | 33462484 | PubTator, text mining | PubMed |
| Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters. | Xenobiotica | 2021 | 33455503 | PubTator, text mining | PubMed |
| Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations. | Int J Mol Sci | 2021 | 33450934 | PubTator, text mining | PubMed |
| Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid. | Pharmaceutics | 2021 | 33435470 | PubTator, text mining | PubMed |
| Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins. | Br J Pharmacol | 2021 | 33434947 | PubTator, text mining | PubMed |
| HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential. | Cancers (Basel) | 2021 | 33430279 | PubTator, text mining | PubMed |
| Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method. | J Clin Med | 2021 | 33418844 | PubTator, text mining | PubMed |
| Silencing GnT-V reduces oxaliplatin chemosensitivity in human colorectal cancer cells through N-glycan alteration of organic cation transporter member 2. | Exp Ther Med | 2021 | 33376510 | PubTator, text mining | PubMed |
| Determining factors of renal dysfunction during cisplatin chemotherapy. | Exp Ther Med | 2021 | 33363594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=44